Moderna Covid-19 Vaccine status

Moderna Covid-19 Vaccine status

Moderna Covid-19 vaccine status is that the company applied for emergency authorization from the U.S. and Europe on Monday.

The Moderna Covid-19 vaccine status is that it has applied for emergency authorization from Europe and USA, on November 30, 2020, to get an approval for their Coronavrius vaccine.

Moderna’s vaccine is the second vaccine that is expected to be authorized for emergency use in the United States this year, following the injection jointly developed by Pfizer and BioNTech. The effective rate of Pfizer’s vaccine is 95%.

Among the more than 30,000 volunteers who participated in Moderna’s vaccine trial, 196 were infected with the Covid 19 virus, of which 185 received a placebo and only 11 received a vaccine. There are 30 severe cases reported by Moderna and these people are all in the placebo group, which means that this vaccine can be 100% effective in preventing severe symptoms.

Moderna’s report on their Moderna Covid-19 vaccine status is that the effectiveness of the vaccine is consistent across demographics of all ages, ethnicities, races and genders, and that for the Coronavirus epidemic that has killed nearly 1.5 million people, the vaccine has a 100% success rate.

The results of a later study by Moderna showed that the vaccine has an effective rate of 94.1% and there are no serious safety risks. Moderna CEO Stephen Bansell is very optimistic about the Moderna Covid-19 vaccine status.

Leave a Reply

Your email address will not be published. Required fields are marked *